{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:43:13Z","timestamp":1778042593133,"version":"3.51.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The FIND-CKD study was funded by Vifor Pharma, Glattbrugg, Switzerland. Medical writing supported was provided by a freelance medical writer funded by Vifor Pharma (C Dunstall)."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157063","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T17:48:46Z","timestamp":1465408126000},"page":"e0157063","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial"],"prefix":"10.1371","volume":"11","author":[{"given":"Carlo A.","family":"Gaillard","sequence":"first","affiliation":[]},{"given":"Andreas H.","family":"Bock","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Carrera","sequence":"additional","affiliation":[]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[]},{"given":"David B.","family":"Van Wyck","sequence":"additional","affiliation":[]},{"given":"Sukhvinder S.","family":"Bansal","sequence":"additional","affiliation":[]},{"given":"Maureen","family":"Cronin","sequence":"additional","affiliation":[]},{"given":"Yvonne","family":"Meier","sequence":"additional","affiliation":[]},{"given":"Sylvain","family":"Larroque","sequence":"additional","affiliation":[]},{"given":"Simon D.","family":"Roger","sequence":"additional","affiliation":[]},{"given":"Iain C.","family":"Macdougall","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice","volume":"98","author":"G Nicholas","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"CH Park","year":"2001","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.2011.141","article-title":"Hepcidin: clinical utility as a diagnostic tool and therapeutic target","volume":"80","author":"DW Coyne","year":"2011","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"L Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"J Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e39783","DOI":"10.1371\/journal.pone.0039783","article-title":"Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents","volume":"7","author":"NC van der Weerd","year":"2012","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e99781","DOI":"10.1371\/journal.pone.0099781","article-title":"The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease","volume":"9","author":"L Mercadel","year":"2014","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","article-title":"Anemia of inflammation","volume":"28","author":"E Nemeth","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2215\/CJN.02190309","article-title":"Hepcidin for clinicians","volume":"4","author":"B Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.23354","article-title":"Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia","volume":"88","author":"DB Bregman","year":"2013","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3324\/haematol.2013.084624","article-title":"Manipulation of the hepcidin pathway for therapeutic purposes","volume":"98","author":"E Fung","year":"2013","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"E Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.2010.254","article-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","volume":"78","author":"BA Ford","year":"2010","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"DR Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000109968","article-title":"Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients","volume":"28","author":"A Kato","year":"2008","journal-title":"Am J Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2362.2009.02182.x","article-title":"Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy","volume":"39","author":"G Weiss","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients","volume":"12","author":"K van der Putten","year":"2010","journal-title":"Eur J Heart Failure"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/nu7010103","article-title":"Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients","volume":"7","author":"K Takasawa","year":"2014","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1093\/ndt\/gfq321","article-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents","volume":"25","author":"N Tessitore","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40620-014-0083-y","article-title":"Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease","volume":"28","author":"S Chand","year":"2015","journal-title":"J Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"D Moretti","year":"2015","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s11255-014-0696-z","article-title":"Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency","volume":"46","author":"LO Br\u0103tescu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"IC Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ndt\/gft424","article-title":"The FIND-CKD study\u2014a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale","volume":"29","author":"IC Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/rcm.4512","article-title":"Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer","volume":"24","author":"SS Bansal","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/cclm-2015-0068","article-title":"Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population","volume":"54","author":"R Pechlaner","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"239476","DOI":"10.1155\/2012\/239476","article-title":"Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators or the iron status of peritoneal dialysis patients","volume":"2012","author":"A Eguchi","year":"2012","journal-title":"Int J Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"J Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"HP Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1177\/147323001103900542","article-title":"Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation","volume":"39","author":"Y Xu","year":"2011","journal-title":"J Int Med Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3324\/haematol.13724","article-title":"New and old players in the hepcidin pathway","volume":"93","author":"C Camaschella","year":"2008","journal-title":"Haematologica"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.05990809","article-title":"Current status of the measurement of blood hepcidin levels in chronic kidney disease","volume":"5","author":"IC Macdougall","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.02690409","article-title":"Hepcidin assays: ironing out some details","volume":"4","author":"J Malyszko","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2009.010322","article-title":"Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization","volume":"94","author":"JJ Kroot","year":"2009","journal-title":"Haematologica"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ajh.23289","article-title":"Second round robin for plasma hepcidin methods: first steps toward harmonization","volume":"87","author":"JJ Kroot","year":"2012","journal-title":"Am J Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:45:10Z","timestamp":1588985110000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157063"}},"subtitle":[],"editor":[{"given":"Kathrin","family":"Eller","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157063","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]}}}